HAL vs NPCE · P/E 9.3, $19.05B cap vs rev $79.9M
Halliburton Company (HAL) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the HAL and NPCE stock pages for the full models.
Not investment advice.